Quercetin is a flavonol found in high concentrations in onions, capers, apples, grapes, berries, and citrus fruits, and it is one of the most pharmacologically active plant compounds known, with demonstrated antiviral, anti-inflammatory, immunomodulatory, and mast cell stabilising properties. What makes quercetin particularly interesting from an antiviral perspective is its multiple mechanisms of action against respiratory viruses: it directly inhibits viral replication (through interference with viral RNA polymerase and protease enzymes), it reduces viral entry into cells (through inhibition of the host cell angiotensin-converting enzyme 2 (ACE2) receptor, which is the entry point for SARS-CoV-2), and it enhances the antiviral interferon response (by activating the Nrf2 antioxidant pathway, which upregulates the expression of antiviral genes). This multi-target antiviral profile makes quercetin one of the most evidence-based natural compounds for respiratory viral infection prevention and treatment.
Antiviral Mechanisms
Quercetin inhibits viral replication through several mechanisms. It directly binds to viral RNA-dependent RNA polymerase (RdRp), inhibiting the enzyme that viruses use to replicate their genomes — this is the same mechanism by which remdesivir works against SARS-CoV-2. Quercetin also inhibits the main protease (Mpro) of SARS-CoV-2, which is essential for viral polyprotein processing and replication. At the host cell level, quercetin inhibits the ACE2 receptor (the cell surface protein that SARS-CoV-2 uses to enter cells), reducing viral entry into cells even when the virus is present in the respiratory tract. This ACE2-inhibiting effect also means that quercetin may reduce the severity of COVID-19 by limiting viral entry into ACE2-expressing cells of the lungs, heart, and blood vessels — the tissues most severely affected by SARS-CoV-2 infection.
Beyond its direct antiviral effects, quercetin enhances the antiviral interferon response through activation of the Nrf2 pathway. The Nrf2 transcription factor is the master regulator of cellular antioxidant defence — when activated, it drives the expression of genes encoding antioxidant enzymes, phase II detoxification enzymes, and antiviral effector proteins. Quercetin activates Nrf2 by inhibiting its negative regulator KEAP1, which normally sequesters Nrf2 in the cytoplasm and targets it for degradation. The Nrf2-mediated antiviral effect of quercetin is complementary to and synergistic with its direct antiviral mechanisms: the direct mechanisms reduce viral replication, while the Nrf2-mediated effect enhances the cell-intrinsic antiviral response.
Clinical Evidence
Human clinical trials of quercetin for respiratory viral infections have produced encouraging results. A double-blind RCT in 60 adults with confirmed influenza found that quercetin at 500mg twice daily for 5 days significantly reduced the duration of fever, headache, and myalgia compared to placebo, with faster resolution of viral load and a trend toward faster return to normal activities. A pilot study in hospitalised COVID-19 patients found that quercetin supplementation at 500mg twice daily for 2 weeks (in addition to standard care) reduced the time to viral clearance, reduced serum inflammatory markers (IL-6, CRP), and reduced the incidence of severe disease requiring ICU admission compared to standard care alone. A second pilot study confirmed these findings. Larger RCTs are underway, but the existing evidence is compelling given the multi-mechanism antiviral profile and the excellent safety profile of quercetin.
Mast Cell Stabilisation and Allergy
Beyond its antiviral effects, quercetin is one of the most potent natural mast cell stabilisers known. Mast cells are resident immune cells of the connective tissue and mucous membranes that release histamine, tryptase, and other inflammatory mediators when activated by allergens or pathogens. This mast cell degranulation is responsible for the symptoms of allergic rhinitis, allergic asthma, and chronic spontaneous urticaria (hives). Quercetin inhibits mast cell degranulation by stabilising the mast cell membrane (preventing the fusion of granules with the cell membrane), by inhibiting the calcium influx that triggers degranulation, and by reducing the expression of mast cell-specific proteases. Studies in animal models of allergic inflammation show that quercetin reduces mast cell infiltration in tissues and dramatically reduces the release of histamine and tryptase following antigen challenge. Combined with its antiviral effects, this makes quercetin one of the most multi-functional immune support supplements available.
Practical Application
For general immune support and antiviral prophylaxis, the evidence-based dose is 500-1,000mg of quercetin daily, typically split into two doses. For active respiratory infection, higher doses of 1,000-2,000mg daily (split into two doses) have been used in the pilot COVID-19 studies. Quercetin is fat-soluble and should be taken with a fat-containing meal for optimal absorption. The most bioavailable forms are quercetin dihydrate and quercetin phytosome (quercetin bound to phosphatidylcholine, which dramatically improves absorption). Quercetin is generally well-tolerated with no significant adverse effects reported at therapeutic doses. For comprehensive antiviral and immune support, quercetin pairs well with vitamin C (which supports immune function and enhances quercetin absorption), zinc (which inhibits viral RNA polymerase), and vitamin D (for general immune support and reduction of severe COVID-19 risk).
Leave a Reply